Press "Enter" to skip to content

Mushrooms Can Now Aid In Electricity Generation With Use Of Non-Renewable Sources

A group of researchers from the Stevens Institute of Technology, New Jersey, have recently discovered a new mode of electricity production using a biological source instead of the conventional fossil fuels.  The bionic mushroom is kind of a mushroom generally covered with specific bacteria.

This wacky finding is something the team dreams of achieving a huge success in the next few years. The mushrooms are home for many bacteria owing to its habitat. However, the idea of generating electricity, oxygen, or even processing oil spills using it is a very interesting subject. But, one of the obstacles here is the survival rate of the cyanobacteria in question owing to the artificial environmental factors.  The scientists have, however, been able to substitute the artificial surface by using the commonly as well as abundantly found button mushrooms as a surface. These surfaces are expected to provide a suitable environment for the bacterial multiplication as the mushroom naturally provides a symbiotic ecosystem for the bacteria to live on.

The technological advancement helps use the 3D printing technology to develop minuscule materials interacting at the microscopic scale. The nanoribbons can be spiraled on the mushroom caps so as to help affix the bacterial cells using the 3D printing. The photosynthetic bioelectricity generation is a new technique wherein a small amount of light on the bacteria can help generate little electricity using bacteria and mushroom as a combinational medium. On a practical scale, according to researcher Dr. Sudeep Joshi, a series of mushroom can be used to produce enough electricity that can light up a tiny lamp. An array of mushrooms helps pack more bacteria and optimize the bio-currents so as to generate the amount of electricity needed to power a petite LED.

Psilocybin, an active ingredient in the mushroom is found to be a naturally occurring psychedelic prodrug amalgam for the depressive illness treatment. Compass Pathways, a British life sciences company the pioneer behind the compound discovery has been given a designation of the Food and Drug Administration’s (FDA) Breakthrough Therapy for its recent drug study and is awaiting the approval of psilocybin based therapy.